Please assess the completion status of the following clinical trial:

Trial Title: Randomized Trial on Effectiveness of ACTs in Ghana

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female outpatients aged 6 months to 59 months~* Absence of severe malnutrition~* A slide-confirmed P. falciparum asexual parasitaemia between 2,000/µl and 200,000/µl~* A measured axillary temperature ≥ 37.5 °C or rectal/tympanic temperature ≥ 38.0 °C~* Absence of general danger signs (unable to drink; repeated vomiting; recent history of convulsions; lethargic or unconscious state; unable to stand up or to sit)~* Ability to tolerate oral therapy~* Permanent residence in study area~* Informed consent by the legal representative of the subject, if possible, the parents~Exclusion Criteria:~* Adequate anti-malarial treatment within the previous 7 days~* Antibiotic treatment for a current infection~* Previous participation in a clinical trial~* Haemoglobin \< 5 g/dl~* Leucocyte count: \> 15000/µl~* Mixed plasmodial infection~* Severe malaria as defined by WHO recommendations~* Any other severe underlying disease (cardiac, renal, hepatic diseases, malnutrition, known HIV infection) or concomitant disease masking assessment of response~* History of allergy or intolerance against trial medication

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Months
- Healthy Volunteers: f

Study Arms:
- AL (Type: EXPERIMENTAL): Artemether plus Lumefantrine 6 dose 3 days treatment
- ASAQ (Type: ACTIVE_COMPARATOR): Artesunate plus Amodiaquine

Based on this trial design, predict the completion outcome and termination type (if applicable).